Demannose

Demannose

SCHEMBL15324263

CC(=O)OCC(N)=O.CC(N)=O.CCCC(=O)OCC(O)CO.O=C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO

nearest known ligand 0.41

Full drug profile on Sugi Atlas →

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.41
DUSP3 P51452 1/20 0.41
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
LMNA P02545 1/20 0.41
DGKA P23743 1/20 0.40
FAAH O00519 4/20 0.38
PRKCA P17252 2/20 0.32
CNR2 P34972 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Acetamide SCHEMBL15323295 0.77 PRKCA (0.31) PRKCA
Acetic Acid SCHEMBL15323296 0.77 KDM4E (0.32) KDM4EDUSP3MEN1KMT2ALMNA
Demannose SCHEMBL28547923 0.75 LMNA (0.38) KDM4EDUSP3MEN1KMT2ALMNA
Acetone SCHEMBL2803680 0.75 MAPT (0.38) KDM4EDUSP3MEN1KMT2ALMNA
Butyric Acid SCHEMBL15324264 0.75 KDM4E (0.31) KDM4EDUSP3MEN1KMT2ALMNA
Demannose SCHEMBL15324262 0.75 FFAR3 (0.33) LMNA
SCHEMBL428467 0.75 MAPT (0.40) KDM4EDUSP3MEN1KMT2ALMNA
SCHEMBL4603636 0.75 MAPT (0.40) KDM4EDUSP3MEN1KMT2ALMNA
Demannose SCHEMBL14248786 0.74 LMNA (0.42) KDM4ELMNA
Acetic Acid SCHEMBL29232673 0.73 KDM4E (0.67) KDM4EDUSP3MEN1KMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2836832-A1 EARLY TRIMESTER SCREENING FOR EARLY- AND LATE-ONSET PREECLAMPSIA Wayne State University (US) 2015-02-18 EP disclosed
WO-2013155458-A1 EARLY TRIMESTER SCREENING FOR EARLY- AND LATE-ONSET PREECLAMPSIA WAYNE STATE UNIVERSITY (US) 2013-10-17 WO disclosed